These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose. Chagla Z Ann Intern Med; 2021 Mar; 174(3):JC29. PubMed ID: 33646835 [TBL] [Abstract][Full Text] [Related]
28. Optimal dosing interval for covid-19 vaccines: we need clinical trial evidence and to consider past infection. Müller-Sedgwick U BMJ; 2021 Feb; 372():n522. PubMed ID: 33627357 [No Abstract] [Full Text] [Related]
30. COVID-19 vaccination in our transplant recipients: The time is now. Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534 [TBL] [Abstract][Full Text] [Related]
31. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection. Xu W; Su S; Jiang S Clin Transl Med; 2021 Feb; 11(2):e331. PubMed ID: 33634979 [No Abstract] [Full Text] [Related]
33. Research on Drugs and Vaccines for COVID-19 Should Be Conducted and Published With Caution. Chen F; Gong S; Li RQ J Epidemiol; 2020 Dec; 30(12):574-575. PubMed ID: 33041320 [No Abstract] [Full Text] [Related]
34. [Development and use of vaccines from the 18th century to the SARS-CoV 2 period]. Skinhøj P; Bygbjerg IC Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734072 [TBL] [Abstract][Full Text] [Related]
35. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Usmani SS; Raghava GPS Front Immunol; 2020; 11():561851. PubMed ID: 33133071 [No Abstract] [Full Text] [Related]
36. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
37. The biosecurity of COVID-19 vaccines. Kantor IN Medicina (B Aires); 2020; 80 Suppl 6():104-106. PubMed ID: 33481741 [No Abstract] [Full Text] [Related]
38. Pregnant people deserve the protection offered by SARS-CoV-2 vaccines. Maykin MM; Heuser C; Feltovich H; Vaccine; 2021 Jan; 39(2):171-172. PubMed ID: 33308888 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality?-Authors' reply. Lanza GA; De Vita A Europace; 2021 Jul; 23(7):1151. PubMed ID: 34077534 [No Abstract] [Full Text] [Related]
40. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control. Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]